AI-generated summary
The authors updated a clinical practice guideline by reviewing studies of mucositis prevention in pediatric cancer and stem cell transplant patients. They report that intraoral photobiomodulation therapy was associated with reduced severe oral mucositis in randomized trials and was feasible across age groups, while cryotherapy was not feasible in young children. The authors also report that palifermin was associated with adverse effects and should not be used routinely.
- Studies included
- 107
- Who or what was studied
- Pediatric cancer and hematopoietic stem cell transplant patients, including some adult patients in randomized trials
- Wavelengths
- 620, 750 nm
- Limits stated in the abstract
- The abstract does not describe certainty of evidence or quality ratings, and the number of participants is not stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 620-750 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Confidence interval, Primary outcome. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.